Gemcitabine Intermediate 9 Bulk Price 2026: Supply Trends & Specs
The global oncology therapeutics landscape is undergoing a significant transformation, driven by the rising incidence of pancreatic and non-small cell lung cancers. Market analysis indicates that the sector is projected to expand from USD 1.53 billion in 2026 to USD 2.75 billion by 2034, exhibiting a robust CAGR of 7.6%. This surge in demand for finished dosage forms directly correlates with the need for reliable, high-quality upstream materials. As generic competition intensifies with over 45 manufacturers entering the space, procurement teams are prioritizing industrial purity and cost-efficiency without compromising regulatory compliance. In this volatile environment, securing a stable supply chain for critical building blocks like Gemcitabine Intermediate 9 is essential for maintaining production continuity and margin protection.
Technical Specifications and Analytical Methods
For process chemists and quality control managers, precise characterization of 3',5'-Di-O-benzoyl-2'-deoxy-2',2'-difluorocytidine is critical. The following table outlines the standard specifications required for pharmaceutical-grade production, ensuring compatibility with downstream coupling reactions.
| Parameter | Specification | Analytical Method |
|---|---|---|
| Appearance | White to Off-White Crystalline Powder | Visual Inspection |
| Assay (HPLC) | NLT 99.0% | HPLC (Area Normalization) |
| Related Substances | Individual Impurity: NMT 0.10% Total Impurities: NMT 0.50% | HPLC |
| Water Content | NMT 0.50% | Karl Fischer Titration |
| Residual Solvents | Compliant with ICH Q3C Guidelines | GC Head-Space |
| Identification | Consistent with Reference Standard | FT-IR / 1H-NMR |
Detailed Chemical Synthesis Route and Reaction Mechanism
The manufacturing process for this Gemcitabine precursor involves the selective protection of the 3' and 5' hydroxyl groups of the difluoronucleoside core. This step is vital to prevent unwanted side reactions during subsequent phosphorylation or coupling stages. The reaction typically utilizes benzoyl chloride in the presence of a base catalyst under controlled low-temperature conditions to ensure regioselectivity.
Optimizing this manufacturing process is key to achieving the high yields necessary for competitive bulk price structures in 2026. Our facility utilizes advanced flow chemistry techniques to enhance reaction control and safety. For detailed technical data sheets regarding the 5'-Di-O-benzoyl-2'-deoxy-2' difluoro structure and its reactivity profile, our technical team provides comprehensive support to R&D departments looking to validate their synthesis pathways.
Strict Quality Assurance (QA) Workflow and COA Verification Process
At NINGBO INNO PHARMCHEM CO.,LTD., we understand that a Certificate of Analysis (COA) is more than a document; it is a guarantee of batch-to-batch consistency. Our QA workflow adheres to strict GMP standards, ensuring that every batch of DFDCT-dibenzoate undergoes rigorous testing before release. This includes multi-point verification of purity, chiral integrity, and residual solvent limits.
For procurement executives, this translates to reduced risk of production delays caused by out-of-specification raw materials. We provide full traceability from raw material sourcing to final packaging, allowing for seamless audit readiness. Our commitment to transparency ensures that the COA provided matches the physical product exactly, facilitating faster QC release times for our partners' API production lines.
As the market evolves towards more complex combination therapies, the demand for high-fidelity nucleoside analogs will continue to rise. Partnering with a global manufacturer that prioritizes both technical excellence and supply chain resilience is the strategic choice for long-term success. NINGBO INNO PHARMCHEM CO.,LTD. remains dedicated to supporting the global pharmaceutical industry with reliable intermediates that meet the toughest regulatory requirements.
For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.